1Department of Neurology, Chungnam National University Sejong Hospital, Sejong, Korea
2Department of Neurology, Chungnam National University College of Medicine, Daejeon, Korea
3Department of Neurology, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea
4Department of Neurology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea
5Department of Neurology, Chungnam National University Hospital, Daejeon, Korea
6Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
7Department of Genomic Medicine, Seoul National University Hospital, Seoul, Korea
8Department of Neurology, Gyeongsang National University Hospital, Jinju, Korea
9Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
10Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
11Department of Neurology, BJ Center for Comprehensive Parkinson Care and Rare Movement Disorders, Chung-Ang University Health Care System, Hyundae Hospital, Namyangju, Korea
Copyright © 2024 The Korean Movement Disorder Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of Interest
The authors have no financial conflicts of interest.
Funding Statement
This work was supported by a focused clinical research grant-in-aid from the Seoul Metropolitan Government-Seoul National University (SMG-SNU) Boramae Medical Center (04-2022-0014) and a research fund of the Chungnam National University Sejong Hospital (2023-S2-008).
Author contributions
Conceptualization: Jee-Young Lee. Data curation: Chaewon Shin, Ryul Kim, Dallah Yoo, Eungseok Oh, Jangsup Moon, Minkyeong Kim. Formal analysis: Chaewon Shin, Ryul Kim, Dallah Yoo, Eungseok Oh, Jangsup Moon, Minkyeong Kim. Funding acquisition: Jee-Young Lee, Chaewon Shin. Investigation: Chaewon Shin, Ryul Kim, Dallah Yoo, Eungseok Oh, Jangsup Moon, Minkyeong Kim. Methodology: Jee-Young Lee, Chaewon Shin, Ryul Kim, Dallah Yoo, Eungseok Oh, Jangsup Moon, Minkyeong Kim. Project administration: Jee-Young Lee, Chaewon Shin. Resources: Jee-Young Lee. Supervision: Jee-Young Lee, Jong-Min Kim, Seong-Beom Koh, Manho Kim, Beomseok Jeon. Validation: Jee-Young Lee, Jong-Min Kim, Seong-Beom Koh, Manho Kim, Beomseok Jeon. Visualization: Chaewon Shin, Ryul Kim, Dallah Yoo, Eungseok Oh, Jangsup Moon, Minkyeong Kim. Writing—original draft: Jee-Young Lee, Chaewon Shin, Ryul Kim, Dallah Yoo, Eungseok Oh, Jangsup Moon, Minkyeong Kim. Writing—review & editing: Jee-Young Lee, Jong-Min Kim, Seong-Beom Koh, Manho Kim, Beomseok Jeon.
It is expected that the ability to define signs and symptoms would be enhanced by longitudinal follow-up and assessments (modified from Ross et al. Mov Disord Clin Pract 2019;6:541-546. [61], under the terms of the Creative Commons Attribution Non-Commercial License [CC BY NC]). Following the diagnostic confidence level of the Unified Huntington’s Disease Rating Scale: 0, normal (no motor abnormalities); 1, nonspecific motor abnormalities; 2, motor abnormalities that may be signs of HD (50%–89% confidence); 3, motor abnormalities that are likely signs of HD (90%–98% confidence); 4, motor abnormalities that are unequivocal signs of HD (> 99% confidence).
HD, Huntington’s disease.
Comments on this article
JEE YOUNG LEE
March 26, 2024
Manho Kim
March 31, 2024